IRTC (iRhythm Technologies) Valuation Rank

View and export this data going back to 2016. Start your Free Trial

What is iRhythm Technologies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

iRhythm Technologies Valuation Rank Related Terms

Thank you for viewing the detailed overview of iRhythm Technologies's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

iRhythm Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (NAS:IRTC) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

0A7L:UK

Address

699 8th Street, Suite 600, San Francisco, CA, USA, 94103

Website

https://www.irhythmtech.com

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Executives

Minang Turakhia	officer: EVP, CMO & CSO	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Daniel G. Wilson	officer: EVP, Strategy Corp Dev Inv Rel	699 8TH STREET, SUITE 600, SAN FRANCISCO CA 94103
Quentin S. Blackford	director, officer: President and CEO	7475 LUSK BLVD., SAN DIEGO CA 92121
Patrick Michael Murphy	officer: CLO & EVP RA/QA MrktAcs & Gov	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Sumi Shrishrimal	officer: EVP, Chief Risk Officer	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Chad Patterson	officer: Chief Commercial Officer	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Abhijit Y Talwalkar	director	ONE AMD PLACE, PO BOX 3453, SUNNYVALE CA 94088
Brice Bobzien	officer: Chief Financial Officer	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Mervin Smith	officer: EVP Strategic Business Ops	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Marc W. Rosenbaum	officer: Chief Accounting Officer	7475 LUSK BLVD., SAN DIEGO CA 92121
Mark J. Day	officer: EVP, Research & Development	C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 500, SAN FRANCISCO CA 94103
Brian B Yoor	director	100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064
Mojdeh Poul	director	3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST PAUL MN 55144-1000
Douglas Devine	officer: Chief Financial Officer	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH STREET, SUITE 600, SAN FRANCISCO CA 94103
Bairey Merz Cathleen Noel	director	16664 CUMBRE VERDE COURT, PACIFIC PALISADES CA 90272